Evidence map›Paper›PMID 37992119›Full record

ArticlePloS one2023

Resistome and virulome of high-risk pandemic clones of multidrug-resistant extra-intestinal pathogenic Escherichia coli (ExPEC) isolated from tertiary healthcare settings in Uganda.

Denis K Byarugaba, Bernard Erima, Godfrey Wokorach, Stephen Alafi, Hannah Kibuuka, Edison Mworozi, Ambrose K Musinguzi, James Kiyengo, Florence Najjuka, Fred Wabwire-Mangen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Extended spectrum beta lactamases and carbapenemase-producingOne health (Amsterdam, Netherlands) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Molecular Analysis ofMicroorganisms · 2024
    Article
  6. Emergence of Carbapenem-Resistant UropathogenicPathogens (Basel, Switzerland) · 2024
    Article
  7. Observational
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Denis K ByarugabaMakerere University Walter Reed Project, Kampala, Uganda.ORCID 0000-0002-4175-5659
Bernard ErimaMakerere University Walter Reed Project, Kampala, Uganda.
Godfrey WokorachMakerere University Walter Reed Project, Kampala, Uganda.
Stephen AlafiMakerere University Walter Reed Project, Kampala, Uganda.
Hannah KibuukaMakerere University Walter Reed Project, Kampala, Uganda.
Edison MworoziMakerere University Walter Reed Project, Kampala, Uganda.
Ambrose K MusinguziUganda Peoples' Defence Forces, Ministry of Defence, Kampala, Uganda.
James KiyengoUganda Peoples' Defence Forces, Ministry of Defence, Kampala, Uganda.
Florence NajjukaCollege of Health Sciences, Makerere University, Kampala, Uganda.
Fred Wabwire-MangenMakerere University Walter Reed Project, Kampala, Uganda.
Makerere University Walter Reed Project · UGGulu University · UGMakerere University · UG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multi-drug resistant (MDR) globally disseminated extraintestinal pathogenic high-risk Escherichia coli (ExPEC) clones are threatening the gains in bacterial disease management. In this study, we evaluated the genomic structure including the resistome and virulome of the E. coli isolates from extraintestinal infections using whole genome sequencing (WGS). The results highlight that isolates were highly resistant (≥ 90.0%) to commonly used antibiotics (Ampicillin, Trimethoprim-Sulfamethoxazole, Nalidixic acid, and Piperacillin) and were less (<14%) resistant to last resort antibiotics; Imipenem (10.94%) and Meropenem (10.20%). A greater proportion of the E. coli isolates belonged to phylogroup B2 (30.52%) and phylogroup A (27.37%). The sequence types ST131 of phylogroup B2 (21.05%) and ST648 of phylogroup F (9.3%) were the dominant pandemic high-risk clones identified in addition to the ST1193, ST410, ST69, ST38, ST405, and ST10. Many of the isolates were MDR and most (64.58%) carried the blaCTX-M-15 gene for extended-spectrum β-lactamases. There was a high correlation between phylogroups and the occurrence of both antimicrobial resistance and virulence genes. The cephalosporin-resistance gene blaEC-5 was only found in phylogroup B2 while blaEC-8 and blaEC-19, were only found within phylogroup D and phylogroup F respectively. Aminoglycoside gene (aadA1) was only associated with phylogroups D and C. The isolates were armed with a broad range of virulence genes including adhesins, toxins, secreted proteases, iron uptake genes, and others. The yfcv, chuA, and kpsE genes preferentially occurred among isolates of phylogroup B2. The study underlines the predominance of MDR internationally disseminated high-risk ExPEC clones with a broad range of virulence genes known to be highly transmissible in healthcare and community settings.

Indexed as

Escherichia coli InfectionsEscherichia coli ProteinsExtraintestinal Pathogenic Escherichia coliAnti-Bacterial Agentsbeta-LactamasesEscherichia coliGenotypeHumansMembrane Transport ProteinsPandemicsTertiary Health CareUgandaVirulence FactorsAnti-Bacterial Agentsbeta-LactamasesEscherichia coli ProteinskpsE protein, E coliMembrane Transport ProteinsVirulence Factors

Identifiers

PMID37992119
PMCPMC10664879
OpenAlexW4388894641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.